Printed Kidney Phantoms Aid Radiation Dosing Calibration
By MedImaging International staff writers Posted on 22 Dec 2016 |

Image: Four differently sized 3D printed phantom kidneys (Photo courtesy of Johannes Tran-Gia).
A new study suggests that three dimensional (3D) printed kidney phantoms could help determine calibration constants in quantitative single-photon emission computed tomography/ computerized tomography (SPECT/CT) imaging.
Researchers at the University of Würzburg (Germany) created a set of four one-compartment kidney dosimetry phantoms and their spherical counterparts, with filling volumes ranging from 8 mL (for newborns) and 123 mL (for adults). The phantom designs were based on the outer kidney dimensions, as provided by medical internal radiation ddose (MIRD) guidelines. Based on the designs, the four refillable, waterproof, and chemically stable models were manufactured using fused deposition polylactide (PLA) modeling on a Conrad (Wernberg-Köblitz, Germany) Renkforce RF1000 FFF 3D printer.
The researchers then applied nuclide-dependent SPECT/CT calibration factors for technetium-99m (Tc-99m), lutetium-177 (Lu-177), and iodine-131 (I-131) to assess the phantoms accuracy when used in quantitative imaging for internal renal dosimetry. The results showed that for the largest phantom, the volumes of interest had to be enlarged by 1.2 mm for 99mTc, 2.5 mm for 177Lu, and 4.9 mm for 131 in all directions to obtain calibration factors comparable to reference. In decreasing phantom volumes, the difference between corresponding sphere–kidney pairs was small, at less than 1.1% for all volumes. The study was published on December 1, 2016, in The Journal of Nuclear Medicine.
“This research shows a way of producing inexpensive models of patient-specific organs/lesions for providing direct and patient-specific calibration constants. This is particularly important for imaging systems suffering from poor spatial resolution and ill-defined quantification, such as SPECT/CT,” said lead author Johannes Tran-Gia, PhD. “With comparably low costs and submillimeter resolution, 3D printing techniques hold the potential for manufacturing individualized anthropomorphic phantoms in many clinical applications in nuclear medicine.”
An imaging phantom is designed to respond in a similar manner to how human tissues and organs would act in order to evaluate, analyze, and tune performance of a specific imaging modality. Phantoms made for radiography may therefore hold various quantities of x-ray contrast agents with absorbing properties similar to normal tissue, so as to tune image contrast or modulate radiation exposure. For ultrasound, on the other hand, a phantom with similar rheological and ultrasound scattering properties to real tissue would be essential, but x-ray absorbing properties would not be needed.
Related Links:
University of Würzburg
Conrad
Researchers at the University of Würzburg (Germany) created a set of four one-compartment kidney dosimetry phantoms and their spherical counterparts, with filling volumes ranging from 8 mL (for newborns) and 123 mL (for adults). The phantom designs were based on the outer kidney dimensions, as provided by medical internal radiation ddose (MIRD) guidelines. Based on the designs, the four refillable, waterproof, and chemically stable models were manufactured using fused deposition polylactide (PLA) modeling on a Conrad (Wernberg-Köblitz, Germany) Renkforce RF1000 FFF 3D printer.
The researchers then applied nuclide-dependent SPECT/CT calibration factors for technetium-99m (Tc-99m), lutetium-177 (Lu-177), and iodine-131 (I-131) to assess the phantoms accuracy when used in quantitative imaging for internal renal dosimetry. The results showed that for the largest phantom, the volumes of interest had to be enlarged by 1.2 mm for 99mTc, 2.5 mm for 177Lu, and 4.9 mm for 131 in all directions to obtain calibration factors comparable to reference. In decreasing phantom volumes, the difference between corresponding sphere–kidney pairs was small, at less than 1.1% for all volumes. The study was published on December 1, 2016, in The Journal of Nuclear Medicine.
“This research shows a way of producing inexpensive models of patient-specific organs/lesions for providing direct and patient-specific calibration constants. This is particularly important for imaging systems suffering from poor spatial resolution and ill-defined quantification, such as SPECT/CT,” said lead author Johannes Tran-Gia, PhD. “With comparably low costs and submillimeter resolution, 3D printing techniques hold the potential for manufacturing individualized anthropomorphic phantoms in many clinical applications in nuclear medicine.”
An imaging phantom is designed to respond in a similar manner to how human tissues and organs would act in order to evaluate, analyze, and tune performance of a specific imaging modality. Phantoms made for radiography may therefore hold various quantities of x-ray contrast agents with absorbing properties similar to normal tissue, so as to tune image contrast or modulate radiation exposure. For ultrasound, on the other hand, a phantom with similar rheological and ultrasound scattering properties to real tissue would be essential, but x-ray absorbing properties would not be needed.
Related Links:
University of Würzburg
Conrad
Latest Nuclear Medicine News
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
- Novel PET Technique Visualizes Spinal Cord Injuries to Predict Recovery
- Next-Gen Tau Radiotracers Outperform FDA-Approved Imaging Agents in Detecting Alzheimer’s
- Breakthrough Method Detects Inflammation in Body Using PET Imaging
- Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients
- Combining Advanced Imaging Technologies Offers Breakthrough in Glioblastoma Treatment
- New Molecular Imaging Agent Accurately Identifies Crucial Cancer Biomarker
- New Scans Light Up Aggressive Tumors for Better Treatment
- AI Stroke Brain Scan Readings Twice as Accurate as Current Method
- AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer
- New Imaging Agent to Drive Step-Change for Brain Cancer Imaging
- Portable PET Scanner to Detect Earliest Stages of Alzheimer’s Disease
Channels
Radiography
view channel
AI Improves Early Detection of Interval Breast Cancers
Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read moreMRI
view channel
New MRI Technique Reveals True Heart Age to Prevent Attacks and Strokes
Heart disease remains one of the leading causes of death worldwide. Individuals with conditions such as diabetes or obesity often experience accelerated aging of their hearts, sometimes by decades.... Read more
AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans
Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read moreUltrasound
view channel.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more